Processa Pharmaceuticals, Inc. Investing Cash Flow
Processa Pharmaceuticals, Inc. (PCSA) reported Investing Cash Flow of -$314.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-14
- Processa Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $186.00K.
- Processa Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$500.00K.
- Processa Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2024-12-31 was $0.00.
- Processa Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2023-12-31 was $0.00.
- Processa Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$850.00K.
- Processa Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$3.24K.
- Processa Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$2.78K.
- Processa Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2018 was -$22.28K, a 102.22% decline from fiscal 2017.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed | Net Cash Provided by (Used in) Investing Activities 27 month | Net Cash Provided by (Used in) Investing Activities 30 month | Net Cash Provided by (Used in) Investing Activities 33 month | Net Cash Provided by (Used in) Investing Activities 36 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $186.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$314.00K 10-Q · filed 2026-08-14 | |||||||||
| 2026-03-31 | -$500.00K 10-Q · filed 2026-05-07 | ||||||||||
| 2025-12-31 | -$850.00K 10-K · filed 2026-03-18 | ||||||||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$3.24K 10-K · filed 2026-03-18 | |||||||||
| 2024-09-30 | -$3.24K 10-Q · filed 2025-11-06 | ||||||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$2.78K 10-K · filed 2025-03-20 | |||||||||
| 2023-09-30 | -$2.78K 10-Q · filed 2024-10-30 | ||||||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $475.50K derived: sum of 2 quarters · filed 2020-03-06 | -$20.50K derived: sum of 3 quarters · filed 2020-03-06 | -$22.28K 10-K · filed 2020-03-06 | |||||||
| 2018-09-30 | $475.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$20.50K derived: sum of 2 quarters · filed 2019-11-14 | -$22.28K 10-Q · filed 2019-11-14 | -$36.62K derived: sum of 4 quarters · filed 2019-11-14 | |||||||
| 2018-06-30 | -$496.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$497.78K 10-Q · filed 2019-08-14 | -$512.12K derived: sum of 3 quarters · filed 2019-08-14 | $508.05K derived: sum of 4 quarters · filed 2019-08-14 | |||||||
| 2018-03-31 | -$1.78K 10-Q · filed 2019-05-14 | -$16.12K derived: sum of 2 quarters · filed 2019-05-14 | $1.00M derived: sum of 3 quarters · filed 2019-05-14 | $1.00M derived: sum of 4 quarters · filed 2019-05-14 | |||||||
| 2017-12-31 | -$14.34K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-08 | $1.01M derived: sum of 2 quarters · filed 2019-04-08 | $1.01M derived: sum of 3 quarters · filed 2019-04-08 | $1.00M 10-K/A · filed 2019-04-08 | |||||||
| 2017-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $1.02M derived: sum of 2 quarters · filed 2018-11-14 | $1.02M 10-Q · filed 2018-11-14 | -$40.77K derived: sum of 4 quarters · filed 2018-11-14 | |||||||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$882.00 10-Q · filed 2018-08-14 | -$1.06M derived: sum of 3 quarters · filed 2018-08-14 | -$1.09M derived: sum of 4 quarters · filed 2018-08-14 | |||||||
| 2017-03-31 | -$882.00 10-Q · filed 2018-05-21 | -$1.06M derived: sum of 2 quarters · filed 2018-05-21 | -$1.09M derived: sum of 3 quarters · filed 2018-05-21 | -$1.07M derived: sum of 4 quarters · filed 2018-05-21 | |||||||
| 2016-12-31 | -$1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-16 | -$1.09M derived: sum of 2 quarters · filed 2018-04-16 | -$1.07M derived: sum of 3 quarters · filed 2018-04-16 | -$1.04M 10-K · filed 2018-04-16 | $17.00K 10-K · filed 2017-09-25 | ||||||
| 2016-09-30 | -$25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | -$10.00K derived: sum of 2 quarters · filed 2017-11-20 | $17.00K 10-Q · filed 2017-11-20 | $58.60K derived: sum of 4 quarters · filed 2017-11-20 | |||||||
| 2016-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-10-04 | $42.00K 10-Q · filed 2017-10-04 | $83.60K derived: sum of 3 quarters · filed 2017-10-04 | $83.60K derived: sum of 4 quarters · filed 2017-10-04 | |||||||
| 2016-03-31 | $27.00K 10-Q · filed 2017-10-04 | $68.60K derived: sum of 2 quarters · filed 2017-10-04 | $68.60K derived: sum of 3 quarters · filed 2017-10-04 | $65.81K derived: sum of 4 quarters · filed 2017-10-04 | |||||||
| 2015-12-31 | $41.60K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | $41.60K derived: sum of 2 quarters · filed 2017-09-25 | $38.80K derived: sum of 3 quarters · filed 2017-09-25 | $40.20K 10-K · filed 2017-09-25 | |||||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | -$2.80K derived: sum of 2 quarters · filed 2017-09-08 | -$1.40K 10-Q · filed 2017-09-08 | -$23.98K derived: sum of 4 quarters · filed 2017-09-08 | |||||||
| 2015-06-30 | -$2.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-30 | -$1.40K 10-Q · filed 2017-08-30 | -$23.98K derived: sum of 3 quarters · filed 2017-08-30 | -$33.93K derived: sum of 4 quarters · filed 2017-08-30 | |||||||
| 2015-03-31 | $1.40K 10-Q · filed 2017-08-07 | -$1.40K 10-Q · filed 2015-05-15 | -$21.18K derived: sum of 2 quarters · filed 2017-08-07 | -$31.13K derived: sum of 3 quarters · filed 2017-08-07 | -$33.13K derived: sum of 4 quarters · filed 2017-08-07 | ||||||
| 2014-12-31 | -$22.58K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | -$32.53K derived: sum of 2 quarters · filed 2017-06-19 | -$34.53K derived: sum of 3 quarters · filed 2017-06-19 | -$44.94K 10-K · filed 2017-06-19 | |||||||
| 2014-09-30 | -$9.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-01 | -$11.95K derived: sum of 2 quarters · filed 2015-12-01 | -$22.36K 10-Q · filed 2015-12-01 | -$22.36K derived: sum of 4 quarters · filed 2015-12-01 | |||||||
| 2014-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | -$12.42K 10-Q · filed 2015-08-19 | -$12.42K derived: sum of 3 quarters · filed 2015-08-19 | -$32.76K derived: sum of 4 quarters · filed 2015-08-19 | |||||||
| 2014-03-31 | -$10.42K 10-Q · filed 2015-05-15 | -$10.42K derived: sum of 2 quarters · filed 2015-05-15 | -$30.76K derived: sum of 3 quarters · filed 2015-05-15 | -$31.82K derived: sum of 4 quarters · filed 2015-05-15 | -$2.88M 10-Q · filed 2014-05-14 | ||||||
| 2013-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-14 | -$20.34K derived: sum of 2 quarters · filed 2015-04-14 | -$21.40K derived: sum of 3 quarters · filed 2015-04-14 | -$27.67K 10-K · filed 2015-04-14 | -$2.87M 10-K · filed 2014-03-27 | ||||||
| 2013-09-30 | -$20.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$21.40K derived: sum of 2 quarters · filed 2014-11-13 | -$27.67K 10-Q · filed 2014-11-13 | -$111.18K 10-Q · filed 2013-11-08 | -$42.05K derived: sum of 4 quarters · filed 2014-11-13 | -$2.95M 10-Q · filed 2013-11-08 | |||||
| 2013-06-30 | -$1.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-19 | -$7.33K 10-Q · filed 2014-08-19 | -$21.71K derived: sum of 3 quarters · filed 2014-08-19 | -$265.98K derived: sum of 4 quarters · filed 2014-08-19 | -$2.85M 10-Q/A · filed 2013-09-06 | ||||||
| 2013-03-31 | -$6.28K 10-Q · filed 2014-05-14 | -$20.65K derived: sum of 2 quarters · filed 2014-05-14 | -$264.93K derived: sum of 3 quarters · filed 2014-05-14 | ||||||||
| 2012-12-31 | -$14.38K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | -$258.65K derived: sum of 2 quarters · filed 2014-03-27 | -$334.34K 10-K · filed 2014-03-27 | ||||||||
| 2012-09-30 | -$244.27K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-08 | -$319.96K 10-Q · filed 2013-11-08 | |||||||||
| 2012-06-30 | -$75.69K 10-Q/A · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |